REC: Interventional Cardiology (English Ed.) (Feb 2022)

Rationale and design of the Concordance study between FFR and iFR for the assessment of lesions in the left main coronary artery. The ILITRO-EPIC-07 Trial

  • Oriol Rodríguez-Leor,
  • José M. de la Torre-Hernández,
  • Tamara García-Camarero,
  • Ramón López-Palop,
  • Bruno García del Blanco,
  • Xavier Carrillo,
  • Juan José Portero-Portaz,
  • Marcelo Jiménez-Kockar,
  • Josep Gómez-Lara,
  • Soledad Ojeda,
  • Fernando Alfonso,
  • Salvatore Brugaletta,
  • Ana Planas del Viejo,
  • José Antonio Linares,
  • Agustín Fernández-Cisnal,
  • Beatriz Vaquerizo,
  • Francisco Fernández-Salinas,
  • José Francisco Díaz-Fernández,
  • Juan Carlos Rama-Merchán,
  • Eduardo Molina,
  • Érika Muñoz-García,
  • Francisco Morales,
  • Ramiro Trillo,
  • Miren Tellería,
  • Juan Rondán,
  • Pablo Avanzas,
  • José Moreu,
  • José Antonio Baz-Alonso,
  • Felipe Hernández,
  • Javier Escaned,
  • Juan Sanchis,
  • Fernando Lozano,
  • Beatriz Toledano,
  • Martí Puigfel,
  • Mario Sádaba,
  • Armando Pérez de Prado

DOI
https://doi.org/10.24875/RECICE.M21000227
Journal volume & issue
Vol. 4, no. 1
pp. 19 – 26

Abstract

Read online

ABSTRACT Introduction and objectives: Patients with left main coronary artery (LMCA) stenosis have been excluded from the trials that support the non-inferiority of the instantaneous wave-free ratio (iFR) compared to the fractional flow reserve (FFR) in the decision-making process of coronary revascularization. This study proposes to prospectively assess the concordance between the two indices in LMCA lesions and to validate the iFR cut-off value of 0.89 for clinical use. Methods: National, prospective, and observational multicenter registry of 300 consecutive patients with intermediate lesions in the LMCA (angiographic stenosis, 25% to 60%. A pressure gudiewire study and determination of the RFF and the iFR will be performed: in the event of a negative concordant result (FFR > 0.80/iFR > 0.89), no treatment will be performed; in case of a positive concordant result (FFR ≤ 0.80/iFR ≤ 0.89), revascularization will be performed; In the event of a discordant result (FFR> 0.80/iFR ≤ 0.89 or FFR ≤ 0.80/iFR> 0.89), an intravascular echocardiography will be performed and revascularization will be delayed if the minimum lumen area is > 6 mm2. The primary clinical endpoint will be a composite of cardiovascular death, LMCA lesion-related non-fatal infarction or need for revascularization of the LMCA lesion at 12 months. Conclusions: Confirm that an iFR-guided decision-making process in patients with intermediate LMCA stenosis is clinically safe and would have a significant clinical impact. Also, justify its systematic use when prescribing treatment in these potentially high-risk patients. Registered at ClinicalTrials.gov ( Identifier: NCT03767621).

Keywords